LATISSE® (bimatoprost ophthalmic solution) 0.03% — the first and only FDA- approved treatment for inadequate or not enough lashes.
HOSPITAL AREA
PATIENT LINKS
LATISSE® (bimatoprost ophthalmic solution) 0.03% — the first and only FDA- approved treatment for inadequate or not enough lashes.
You must be logged in to post a comment.